|
CAMLG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.522100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.540940E-03 |
| Normal-vs-Stage2 |
1.355160E-01 |
| Normal-vs-Stage3 |
6.364400E-01 |
| Normal-vs-Stage4 |
6.744400E-02 |
| Stage1-vs-Stage2 |
4.677000E-01 |
| Stage1-vs-Stage3 |
7.144700E-03 |
| Stage1-vs-Stage4 |
1.263870E-02 |
| Stage2-vs-Stage3 |
1.657780E-01 |
| Stage2-vs-Stage4 |
2.523800E-02 |
| Stage3-vs-Stage4 |
6.523600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.299100E-03 |
| Normal-vs-AfricanAmerican |
6.173700E-02 |
| Normal-vs-Asian |
2.430400E-01 |
| Caucasian-vs-AfricanAmerican |
7.289600E-01 |
| Caucasian-vs-Asian |
3.924600E-03 |
| AfricanAmerican-vs-Asian |
2.031500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.983800E-04 |
| Normal-vs-Female |
9.279600E-01 |
| Male-vs-Female |
2.002400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.345800E-01 |
| Normal-vs-Extreme_Weight |
7.917900E-03 |
| Normal-vs-Obese |
5.490000E-02 |
| Normal-vs-Extreme_Obese |
2.136200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.484370E-01 |
| Normal_Weight-vs-Obese |
3.579000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.136000E-01 |
| Extreme_Weight-vs-Obese |
6.767800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.240400E-01 |
| Obese-vs-Extreme_Obese |
7.815600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.760000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.552780E-01 |
| Normal-vs-Age(61-80Yrs) |
8.16460000000463E-05 |
| Normal-vs-Age(81-100Yrs) |
3.652200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.198210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.356200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.925600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.022200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.936800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.688790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.26909999999636E-05 |
| Normal-VS-Type2 PRCC |
5.083400E-01 |
| Normal-VS-KIRP CIMP |
8.552600E-01 |
| Normal-VS-Unclassified PRCC |
6.172400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.13599999995717E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.051500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.995500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.723400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.440800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.620600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.514000E-01 |
| Normal-vs-N1 |
1.821980E-01 |
| Normal-vs-N2 |
4.244200E-01 |
| N0-vs-N1 |
7.444400E-02 |
| N0-vs-N2 |
4.739200E-01 |
| N1-vs-N2 |
8.803000E-01 |
|
|
